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Histone modiﬁcations are regarded as one of markers to identify regulatory elements which are DNA seg-
ments modulating gene transcription. Aberrant changes of histone modiﬁcation levels are frequently
observed in cancer. We have employed ChIP-Seq to identify regulatory elements in human breast cancer
cell line, MCF-7 by comparing histone modiﬁcation patterns of H3K4me1, H3K4me3, and H3K9/14ac to
those in normal mammary epithelial cell line, MCF-10A. The genome-wide analysis shows that H3K4me3
and H3K9/14ac are highly enriched at promoter regions and H3K4me1 has a relatively broad distribution
over proximity of TSSs as well as other genomic regions. We identiﬁed that many differentially expressed
genes in MCF-7 have divergent histone modiﬁcation patterns. To understand the functional roles of dis-
tinctively histone-modiﬁed regions, we selected 35 genomic regions marked by at least one histone mod-
iﬁcation and located from 3 to 10 kb upstream of TSS in both MCF-7 and MCF-10A and assessed their
transcriptional activities. About 66% and 60% of selected regions in MCF-7 and MCF-10A, respectively,
enhanced the transcriptional activity. Interestingly, most regions marked by H3K4me1 exhibited an
enhancer activity. Regions with two or more kinds of histone modiﬁcations did show varying activities.
In conclusion, our data reﬂects that comprehensive analysis of histone modiﬁcation proﬁles under cell
type-speciﬁc chromatin environment should provide a better chance for deﬁning functional regulatory
elements in the genome.
 2012 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
The hierarchical folded structure of eukaryotic DNA forms
nucleosome, chromatin ﬁber, and eventually chromosome in the
nucleus [1]. A nucleosome, basic unit of chromatin consists of
two copies of four core histones (H2A, H2B, H3, and H4) wrapped
by 146 bp of DNA [2]. The N-terminal tails of histones are subject
to various types of post-translational modiﬁcations such as acety-
lation, methylation, phosphorylation, ubiquitination, glycosylation,
and sumoylation [3]. The dynamic addition and removal of these
modiﬁcations carried out by histone modifying enzymes have been
known to affect changes of chromatin structure so as to provide
binding sites for proteins and to modulate cellular processes such
as transcription, repair, replication, and genome stability [4–7].
Many genome-wide approaches to proﬁling histone modiﬁcations,
especially ChIP-Seq, have revealed the characteristic genomic dis-Y-NC-ND license. 
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9 8179.tribution and the association of gene functions and activities in
various model organisms [8–14]. For example, H3K4me3 andmany
histone acetylations usually exist in promoter regions and posi-
tively correlated with gene transcriptional levels. Trimethylation
of H3K27 is likely to spread over larger regions around TSSs of si-
lent genes. The signals of trimethylations of H3K9 and H4K20 are
high in silent genes and repressed chromatin domains. Many his-
tone acetylation patterns are site-speciﬁc along the whole genome
and are linked to transcriptional activation more or less [12,15].
The comprehensive analysis of many histone modiﬁcations in the
human genome demonstrates that the combination of several his-
tone modiﬁcations forms a modular pattern and inﬂuences tran-
scriptional activation in a cooperative manner [15,16].
The availability of many genomic sequences from different
organisms facilitates the discovery of functionally signiﬁcant se-
quences by comparative genomics approach. However, the se-
quence comparison and mathematical modeling are not sufﬁcient
for discrimination of all functional elements from the bulk of the
genome [17]. Besides evolutionary conserved sequences, many
functional elements could be found by examining chromatin
accessibility and histone modiﬁcation or DNAmethylation patterns
[18–23]. A representative international project aiming to ﬁnd all
functional elements in the human genome called the Encyclopedia
of DNA Elements (ENCODE) pilot project has examined about 1%
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[24]. Many functional elements examined by the ENCODE project
are likely unconstrained acrossmammalian evolution and comprise
a large reservoir of functionally conserved but non-orthologous
elements between species as well as lineage-speciﬁc elements.
The histonemodiﬁcationmapping could provide highly informative
signatures to the estimation of presence and activity of gene
promoters and distal regulatory sites. For the prediction of
enhancers located in the non-coding region and enhancing the
promoter activity by forming loop structure, several groups have
ﬁnished genome-wide mapping of histone acetylation and
methylation, DNase I hypersensitive sites, and p300 binding sites
[11–13,15,19–21,25]. But not all the predicted enhancer candidates
were validated due to the absence of proper assay condition closely
mimicking the in vivo environment.
Breast cancer is a heterogeneous and progressive disease known
as themost common cancers amongwomen [26]. For the purpose of
earlydiagnosis andprognosis, ﬁnding tumormakers inbreast cancer
is important but at present, no markers are available for its early
detection [27,28]. The most clinically useful tissue-based markers
in breast cancer are steroid receptors, estrogen receptors, progester-
one receptors and HER-2 [27,29]. The mutations of BRCA1 and
BRCA2 are strong indicators of breast cancer development but their
occurrence is rare, in less than one out of 1000 patients [27]. Obvi-
ously, the perturbation of well-regulated gene expression program
by epigenetic malfunction or other reason affects deregulation of
cellular network leading to a tumor progression. In breast cancer,
the loss of H4K20me3 and elevation of histone H4 acetylation are
associated with aberrant expression of DNMT1 and Suv4-20h2
[30]. To further understand epigenetic regulatory mechanism on
gene expression through differential histone modiﬁcations in nor-
mal and breast cancer cells, we performed ChIP-Seq analysis of
H3K4me1, H3K4me3, and H3K9/14ac. We identiﬁed 140,691 and
115,000 peaks for H3K4me1, 23,979 and 22,306 for H3K4me3, and
23,579 and 24,716 for H3K9/14ac, in MCF-7 and MCF-10A, respec-
tively.Werandomly selected35 regions locatedseveral kbupstream
of TSSs andmeasured their transcriptional activitiesby luciferase re-
porter assay. Themajority of enhancer candidates examined (23/35,
21/35) enhanced the transcriptional activity both in MCF-7 and
MCF-10A, respectively. Interestingly, about 23% (8/35) of candidates
were dramatically activated (at least >5-fold) inMCF-7 compared to
the same candidate sequences in MCF-10A, implying that the envi-
ronment of each enhancer is speciﬁc to cell types.2. Materials and methods
2.1. Cell culture
MCF-7, an invasive ductal carcinoma cell line, was cultured in
DMEM media supplied with 10% FBS and 50 U/ml penicillin and
50 lg/ml streptomycin. MCF10-A cells (ATCC, CRL-10317) were
maintained in DMEM/F12 supplemented with 5% horse serum,
20 ng/ml EGF, 10 lg/ml insulin, 1 ng/ml cholera toxin, 100 lg/ml
hydrocortisone, 50 U/ml penicillin, and 50 lg/ml streptomycin
[31].2.2. Preparation of chromatin and immunoprecipitation
After harvesting, 2  107 cells were suspended with 850 ll of
ice-cold digestion buffer (50 mM Tris–HCl, pH 7.6, 1 mM CaCl2,
0.2% Triton X-100, 5 mM butyrate, 1 proteinase inhibitor cocktail,
and 0.5 mM fresh PMSF). The cells were incubated with 0.3 U of
Micrococcal nuclease (Sigma, N3757) for 5 min at 37 C and the
reaction was stopped by adding 90 ll of 50 mM EDTA. The dialyzed
mononucleosomes with RIPA buffer (10 mM Tris, pH 7.4, 1 mMEDTA, 0.1% SDS, 0.1% Na-Deoxycholate, 1% Triton X-100) were sub-
ject to immunoprecipitation with antibodies against H3K4me1
(Abcam, ab8895), H3K4me3 (Abcam, ab8580), H3K9/K14ac (Ab-
cam, ab4441), and IgG (Santa Cruz, sc2025) [13]. After isolating
ChIPed DNA, the efﬁciency and reproducibility of ChIP were vali-
dated by PCR.
2.3. Generation of sequencing library and ChIP-Seq analysis
Approximately 200 ng of ChIPed and input DNA were repaired
using the End-It DNAEnd-repair kit (Epicentre Biotechnologies), fol-
lowed by addition of 30 A nucleotide for adaptor ligation. Overnight
ligation of polished ChIPed DNA with Genomic DNA Adaptors from
Illumina, ampliﬁcation for 18 cycles, and isolation of about 220 bp
from agarose gel were performed according to manufacturer’s pro-
tocol. ThisChIP-Seq librarywas sequencedby IlluminaGenomeAna-
lyzer II. Sequence reads were aligned to human reference sequence
(hg18) using CASABA 1.6 provided by Illumina. In MCF-7 cells, total
mapped tag counts for H3K4me1, H3K4me3, H3K9/14ac, and input
were 10.4, 2.2, 2.3, and 9.3 million reads, and in MCF-10A cells,
12.3, 9.8, 7.4, and 17.9 million reads, respectively. The normalized
sequence readswereused for the further analysis [13]. The sequence
data are deposited into the Sequence Read Archive (SRA) at the Na-
tional Center for Biotechnical Information (NCBI) (SRA045635). To
identify peaks enriched with a speciﬁc histone modiﬁcation, the
HOMER (Hypergeometric Optimization of Motif EnRichment) ver.
3.2 was used with the following options; approximate fragment
length = 150 bp, peak size = 150 bp, minimum distance between
peaks = 370 bp (equivalent to peak size 2.5), Poisson p-value
threshold relative to local tag count = 0.0001, default false discovery
rate (FDR) threshold = 0.001, and center switch for centering peaks
on maximum ChIP fragment overlap and calculating focus ratios
[32]. The gene expression data using Affymetrix Human Genome
U133Plus2.0 arrayplatformwasobtained fromtheGeneExpression
Omnibus (GEO) at NCBI (GSM276046  GSM276048 for MCF-7;
GSM275995 GSM275996 for MCF-10A) [33].
2.4. Luciferase reporter assay
Potential regulatory elements for measuring the transcriptional
activities were selected on a basis of histone modiﬁcation peak
around 3–10 kb upstream of TSS (Supplementary Table S1). The
regulatory element candidates ranging from 400 to 800 bp in
length were ampliﬁed and cloned into the pGL3-HS vectors which
were prepared by inserting minimal heat-shock promoter from
pIND vector [34]. All cloned elements were conﬁrmed by conven-
tional DNA sequencing. One microgram of each reporter construct
was transferred into both MCF-7 and MCF-10A cells using Gene-
juice transfection reagent (Novagen) following manufacturer’s
instruction. Cells were lysed 24 h after transfection and the lucifer-
ase activities at least in duplicate were measured using Dual-Lucif-
erase Reporter Assay System (Promega). The regulatory element
activities were normalized to basal activity of pGL3-HS vector.3. Results
3.1. Genome-wide distribution of histone modiﬁcation analyzed by
ChIP-Seq
To map the genomic positions associated with H3K4me1,
H3K4me3, and H3K9/14ac, we carried out ChIP-Seq analysis after
validating ChIP efﬁciency and reproducibility by PCR (Supplemen-
tary Fig. S1). Using the HOMER, we identiﬁed 140,691 and 115,000
peaks of H3K4me1, 23,979 and 22,306 peaks of H3K4me3, 23,579
and 24,716 peaks of H3K9/14ac in MCF-7 and MCF-10A,
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H3K4me1 signals at promoters including 1 kb upstream and down-
stream of the TSS occupy 5% and 6% of the human genome in MCF-
7 and MCF-10A, respectively, which is greater than that of the hu-
man genome (1%). The levels of H3K4me3 and H3K9/14ac at pro-
moters are much higher in two cell types (23–30% of the
genome) than those of H3K4me1. In particular, the highest peaks
of H3K4me3 and H3K9/14ac appear at the immediate downstream
of TSS, reﬂecting that the ﬁrst nucleosome of genes is the major
targets of these two modiﬁcations (Fig. 1B). The genomic enrich-
ment of H3K4me1 is relatively broad near the TSS. The overall peak
pattern of each modiﬁcation in both MCF-7 and MCF-10A is quite
similar. The peak distributions of histone modiﬁcations in Fig. 1C
show that the H3K4me1 peaks are located in the exon, intron, 50-
and 30-untranslated regions (UTRs), and even far upstream and
downstream of genes. But most H3K4me3 and H3K9/14ac peaks
are located in the 50-UTR.Human 7-FCM
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Fig. 1. Genome-wide occupancy of histone modiﬁcations in MCF-7 and MCF-10A. (A) T
(±1 kb regions from TSS), gene body, and intergenic regions. The sequence allocation of
H3K9/14ac were plotted ranging from 3 to +3 kb of the TSSs. The Y axis represents th
modiﬁcation peaks was shown in detail.3.2. Correlation of histone modiﬁcations in MCF-7 and MCF-10A
To see whether the histone modiﬁcations in cancer and normal
cells occurs at the same region, we calculated Pearson’s correlation
coefﬁcients between two histone modiﬁcation levels of all anno-
tated genes’ promoters, which are deﬁned as log 2 values of sum
of normalized tag counts detected within 1 kb upstream and
downstream of TSS. As expected, the pair-wise correlation coefﬁ-
cients of H3K4me3 and H3K9/14ac in each cell type show the high-
est values, 0.86 and 0.90 in MCF-7 and MCF-10A, respectively
(Fig. 2A). The correlation coefﬁcients of the same histone modiﬁca-
tion in different cell types are 0.65 for H3K4me1, 0.59 for
H3K4me3, and 0.70 for H3K9/14ac. The cross-coefﬁcient of
H3K4me3 in MCF-7 and H3K9/14ac in MCF-10A is 0.60 and that
of H3K9/14ac in MCF-7 and H3K4me3 in MCF-10A is 0.67. The cor-
relation of H3K4me3-H3K9/14ac in the same cell type (0.86 and
0.90) is more signiﬁcant than that of H3K4me3-H3K9/14ac inA01-FCM
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Fig. 2. Colocalization of histone modiﬁcations in MCF-7 and MCF-10A cells. (A) A heatmap was generated from Pearson’s correlation coefﬁcients for histone modiﬁcation
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tions in different cell types (0.65, 0.59, and 0.70). The interaction
of H3K4me1 with other histone modiﬁcation is generally weaker
in the promoter regions. The genome-wide correlations of
H3K4me1 with H3K4me3 (0.003 for MCF-7 and 0.061 for MCF-
10A) and H3K9/14ac (0.012 for MCF-7 and 0.152 for MCF-10A)
are not as strong as those in the promoter regions. The colocaliza-
tion of two histone modiﬁcations is shown in Fig. 2B and C where
H3K4me1 or H3K9/14ac peaks are centered and the distribution of
the other two histone modiﬁcations are plotted. When the distance
between center positions of two peaks considered was shorter than
100 base pairs, two peaks were regarded as colocalized ones. In
both MCF-7 and MCF-10A, the H3K9/14ac peaks are considerably
overlapped with H3K4me3 but the H4K4me1 peaks are not.
3.3. Gene expression and histone modiﬁcations in MCF-7 and MCF-10A
To understand the relationship between histone modiﬁcation
and gene expression, we compared our ChIP-Seq datawith the open
source gene expression data for MCF-7 and MCF-10A. The geneexpression levels are positively correlated with H3K4me3
(R2 = 0.6141 and R2 = 0.9062) and H3K9/14ac (R2 = 0.8869 and
R2 = 0.9374) inMCF-7andMCF-10Awhenplottedwith17,614anno-
tated genes (Fig. 3A, Supplementary Fig. S3). But the H3K4me1 sig-
nals exhibit relatively low correlation coefﬁcients as previously
reported [13]. In MCF-7 cells, the promoters of 2648 genes were
more acetylatedby at least 2-fold onH3K9/14 and the gene ontology
(GO)analysis by theDatabase forAnnotation,Visualizationand Inte-
grated Discovery (DAVID) tools revealed that they are associated
with the followingGOcategories;DNApackaging, intracellularorga-
nelle lumen, cell morphogenesis, metal ion binding, regulation of
cellular process, replisome, DNA processing, cell cycle, peroxisome,
and transcription [35] (Supplementary Fig. S4). The functional clas-
siﬁcation was similar to that for up-regulated genes in MCF-7 cells
(Supplementary Fig. S4). Interestingly, breast cancer-related genes
up-regulated in MCF-7 are likely to have high level of H3K9/14ac.
We identiﬁed 21 genes (DRD2, PRDM2, PTPRJ, CTCF, XRCC3,
SULT1A1, AURKA, GSTZ1, MYCL1, BARD1, CDT1, CCND1, NCOA3,
RAD51C, PRLR, IRS1, CXCL12, BRIP1, CALCR, CBS, and ESR1) from
the cluster analysis of H3K9/14ac and expression of breast
Fig. 3. Gene expressionproﬁles andhistonemodiﬁcations. (A) Theexpression levels of17,614geneswerecompared tohistonemodiﬁcation levels. Insets are regressioncoefﬁcients
(R2). (B)Agroupofbreast-cancer relatedgeneswere selectedandcalculated the foldchangesofH3K9/14acandexpression levels.Geneswere sortedbygeneexpression level. (C) The
H3K9/14ac pattern for near ESR1 was shown and the TSS of ESR1 is denoted by arrow. The bar graph displays levels of H3K9/14ac and expression for ESR1.
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estrogen receptor alpha (ESR1) is highly acetylated on H3K9/14ac
and the over-expression of ESR1 is observed in MCF-7 (Fig. 3C).
3.4. Identiﬁcation of regulatory elements in MCF-7 and MCF-10A
To ﬁnd unknown regulatory elements which may enhance the
promoter activity, we deﬁned the histone modiﬁcation peaks usingthe HOMER where signiﬁcant peaks were determined by assuming
that the local density of tags follows a Poisson distribution and cal-
culating the expected number of false positives in the dataset for
each tag threshold speciﬁed (FDR = 0.001) using the expected dis-
tribution of peaks (Supplementary Fig. S2 and an example (#5) in
Supplementary Fig. S5). The histone modiﬁcation peaks located
about 3–10 kb upstream of TSS are shown in Fig. 4A where consid-
erable number of peaks is not overlapped each other. Only a small
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H3K9/14ac) is colocalized in the same chromatin region in MCF-7.
Among them, only 10 peaks contain all three histone modiﬁca-
tions. In MCF-10A, the overlapped peak ratios are 4.3%, 12.3%,
and 32% for H3K4me1, H3K4me3, and H3K9/14ac, respectively.
To explore the functional role of these histone modiﬁcation peaks,
we randomly selected 35 peak regions and tested transcriptional
activity (Fig. 4B, Supplementary Table S1). An interesting example
with differential H3K4me1 level in Fig. 4C is an upstream sequence
of BTG3-associated nuclear protein (BANP) gene, a human homo-
logue of tumor suppressor SMAR1 which is one of p53 target genes
[36]. Considering 11.9-fold enrichment of the reporter gene activ-
ity in MCF-7 and 5.4-fold in MCF-10A, this region (clone #2) can be
regarded as a strong enhancer. Out of 35 potential regulatory ele-
ments, 23 candidates (66%) in MCF-7 and 21 (60%) in MCF-10Aincreased the reporter activity by at least 2-fold (Fig. 4D, Supple-
mentary Table S1). As shown in Fig. 4B and D, the reporter assay
revealed that 65% (11/17) and 77% (10/13) of monovalent potential
enhancer elements exhibit elevated activities in MCF-7 and MCF-
10A, respectively. The di- or trivalent elements also demonstrate
high levels of activation, 80% (8/10) in MCF-7 and 64% (7/11) in
MCF-10A. Interestingly, 50% (4/8) in MCF-7 and 36% (4/11) in
MCF-10A are classiﬁed as enhancers even though they are not re-
garded as peaks by the HOMER. Even though the activities of the
same element sequences were measured in both MCF-7 and
MCF-10A, they showed divergent activities such that multivalent
elements were likely to show higher activation than monovalent
elements with some exceptions depending on cell type and chro-
matin environment. For example, clone #14 is activated by 5-fold
in MCF-7 but not in MCF-10A.
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Like other cancers, breast cancer cannot be driven only by ge-
netic abnormalities but also by epigenetic alterations [26,37,38].
In this study, we analyzed high-resolution distribution of
H3K4me1, H3K4me1, and H3K9/14ac by ChIP-Seq in breast cancer
cell, MCF-7 and normal cell, MCF-10A. As known previously, the
promoter regions have high levels (>23%) of H3K4me3 and
H3K9/14ac compared to 1% of genomic occupancy while
H3K4me1 is pervasively distributed. We tried to ﬁnd global differ-
ences in histone modiﬁcation proﬁles between two cell lines but as
seen in Fig. 1C, each region does not show signiﬁcant changes,
reﬂecting that histone modiﬁcations have their own propensity
for binding to a speciﬁc region.
The pair-wise correlation study for H3K4me3 and H3K9/14ac
indicates that these two modiﬁcations are greatly colocalized each
other in the same cells but their correlation in different cells is
moderate. The promoters with high levels of H3K4me3 also occupy
elevated H3K9/14ac in one cell line. A comparison between two
different cell types indicates that the correlations between
H3K4me3-H3K4me3, H3K4me3-H3K9/14ac, and H3K9/14ac-
H3K9/14ac are not as high as those in the same cells. This pair-wise
correlation result is consistent with gene expression level shown in
Fig. 3A where the gene expression levels are positively regulated
by H3K4me3 and H3K9/14ac.
We examined histone modiﬁcation patterns and gene expres-
sion level of breast cancer speciﬁc genes using DAVID Functional
Annotation tool and identiﬁed 21 breast cancer-associated genes.
The level of H3K9/14ac rather than H3K4me3 of these genes was
well correlated with the degree of expression in MCF-7 (data not
shown). The heat map analysis of H3K9/14ac and gene expression
in MCF-7 demonstrates 21 plausible genes which are highly ex-
pressed, much acetylated, and especially related with breast can-
cer. These genes may be used as diagnostic markers if they are
validated in a future experiment exploring in breast cancer
patients.
The identiﬁcation of cancer cell-speciﬁc functional elements is
beneﬁcial for early detection or prognostic improvement. We de-
ﬁned 140,691 and 115,000 H3K4me1 peaks in MCF-7 and MCF-
10A. Because it was practically impossible to examine all peaks de-
ﬁned, we determined the following scope to assay selected peaks;
(i) located in 3–10 kb distant from the TSS, (ii) equally distributed
according to presence or absence of three histone modiﬁcations
shown in Fig. 4A, and (iii) transfected successfully in both MCF-7
and MCF-10A. Apparently, over 60% of selected peaks increased
the reporter gene activity and thus they might be regarded as
enhancers even though stringent evaluation in vivo still remains.
We tested only handful candidates for regulatory elements but
the result was enough to shed a light on deﬁning breast cancer
cell-speciﬁc regulatory elements which could eventually be used
as clinical markers. In summary, our approach in this study could
make a meaningful contribution to identiﬁcation of cell-type spe-
ciﬁc elements able to be used as a clue for understanding epige-
netic alterations during disease progression.
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